Introduction Executive Summary Lyme Disease: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Lyme Disease – DelveInsight’s Analytical Perspective Mid Stage Products (Phase II) • Comparative Analysis VLA 15: Valneva • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis CT 38: Cortene • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical and Discovery Stage Products • Comparative Analysis Lyme disease vaccine - Introvacc • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Lyme Disease Key Companies Lyme Disease Key Products Lyme Disease- Unmet Needs Lyme Disease- Market Drivers and Barriers Lyme Disease- Future Perspectives and Conclusion Lyme Disease Analyst Views Lyme Disease Key Companies Appendix

Table 1 Total Products for Lyme Disease Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Valneva • Cortene • Flightpath Biosciences • Introvacc • Inovio Pharmaceuticals • Greffex • Abzyme Therapeutics • Tarus Pharmaceuticals